New FDA-Approved Treatment for RKD

The FDA has approved Ultomiris for adults with IgA Nephropathy (IgAN). More information coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Michael Levine

President

Michael Levine is a New York native who resides in Melville, NY and is a proud husband to Dana, and father of daughter Sydney and son Matthew. Michael is a graduate of Syracuse University with study focus in Political Science and Economics. Professionally, he has served as the President of L&L Painting for over 15 years. In 2006, at the age of 2, Matthew was diagnosed with FSGS. Michael quickly found NephCure and has been actively committed to its mission ever since. He has been an active member of NephCure’s Board of Directors for over 10 years and has been serving on the board’s Executive Committee for most of that time. Michael has been annually running and expanding the organization’s signature event, ‘Countdown to a Cure’ building upon its success from fellow board member Ron Cohen, in addition to conducting the annual ‘All-in for a Cure’ golf and banquet event for many years. These events have raised millions of dollars to support NephCure’s mission. Time with family and routinely connecting with and supporting patients and families are the hallmarks of Michael’s desire to help others.

Melville, NY

Related News

NEWS

The FDA Grants Accelerated Approval of ULTOMIRIS (ravulizumab-cwvz) for Adults with IgA Nephropathy 

NEWS

NephCure Applauds U.S. Department of Health and Human Services on the Release of the Rare Kidney Disease Inclusive Kidney Care National Plan

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.